3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Colorectal Neoplasms
8
Breast Neoplasms
7
Uterine Cervical Neoplasms
5
Lung Neoplasms
5
Hematopoietic and Lymphatic System Neoplasm
4
Papillomavirus Infections
3
Liver Neoplasms
2
Hematologic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma, Hepatocellular
2
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Overweight
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma
1
Liver Diseases
1
HER2+ Metastatic Breast Cancer (MBC)
1
Fibrosis
1
Diabetes Mellitus
1
Colorectal Cancer Screening
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Cancer Screening
1
Interventions
pembrolizumab
90
Blood Specimen Collection
41
Cyclophosphamide
37
Bevacizumab
36
Nivolumab
35
Standard of Care
32
Carboplatin
31
Surveys and Questionnaires
29
Paclitaxel
27
atezolizumab
25
Exercise
25
Pemetrexed
24
Gemcitabine
24
Cisplatin
23
Fluorouracil
22
Radiotherapy
20
Leucovorin
20
Dexamethasone
20
Docetaxel
19
Oxaliplatin
18
Rituximab
16
Irinotecan
16
Cetuximab
16
dostarlimab
15
Drug Therapy
15
Doxorubicin
15
Ipilimumab
14
Biopsy
14
130-nm albumin-bound paclitaxel
14
fludarabine
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Patient Navigation
×
1 year
×
Clear all
NCT04234646
2026-06-02
Patient Navigation 2.0
Northwestern University
Phase NA
Completed
600 enrolled